AzTrials
AzTrials

BedwettingNCT05214131

Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm

A study testing gogoband and SNEA group in people with Bedwetting and Nocturnal Enuresis, run by Yale University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record

Search all trials

Trial summary

Identify the dry night rate in patients using the GoGoband® nocturnal enuresis device vs a standard Pflaundler bedwetting alarm. Read more about this study

Who is it for?
Ages 6 to 21 yearsHealthy volunteers can take part
What is being tested?
gogoband and SNEA group
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
29 Apr 2022to 13 Jun 2025
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 21 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged 6 to 21 years
  • In good general health as evidenced by medical history and diagnosed with MNE
  • Ability to and be willing to adhere to the treatment regimen. -

Who cannot join

  • No patient may have had treatment of MNE in the past 6 months whether with medications or alarms
  • Current use of on ADHD medications, Tricyclics, SSRI's, NRI's or any antipsychotic medications.
  • Presence of Autistic Spectrum disorder, ADHD, genetic syndrome associated with developmental or learning disabilities
  • Treatment with another investigational drug or other intervention within last 6 months
  • Any form of Diabetes Mellitus or Diabetes Insipidus
  • No patient with known Chronic renal disease with moderate to severe renal impairment (defined as a creatinine clearance below 50mL/min).
  • No patient with known hyponatremia or a history of hyponatremia.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Yale New Haven Health

    New Haven, Connecticut, 06520

Other trials in United States

About this study

Official title: Randomized Study Of Novel Enuresis Alarm (GoGoband® )Vs Standard Nocturnal Enuresis Alarm (SNEA)

Identify the dry night rate in patients using the GoGoband® nocturnal enuresis device vs a standard Pflaundler bedwetting alarm.

Read the detailed description

3.1 Problem Statement At the present time, there are no side-by-side comparison studies of GoGoband® vs SNEA. Since many of the prior studies were conducted using variable outcome parameters that makes direct comparisons of studies difficult it would be beneficial to obtain comparable data from the 2 groups and compare dry night rates for the 2 devices.

3.2 Purpose of Study/Potential Impact Our preliminary quality improvement data indicates that the GoGoband® is more efficacious than both medication and SNEA in an uncontrolled environment when deidentified data was analyzed off our servers. Our present database does not allow us to discern if patients are monosymptomatic nocturnal enuresis (MNE) or non monosymptomatic nocturnal enuresis (NMNE). Without this ability as well as for controlling for behavioral and academic problems which are known to affect outcomes in nocturnal enuresis studies, the investigators are not able to compare our results definitively and accurately to other treatment modalities.

Hypothesis Our hypothesis is that the GoGoband® is more effective than SNEA and Desmopressin in the treatment of Nocturnal Enuresis Primary Objective The primary objective of this study is to determine whether the GoGoband®] is as effective or more effective in comparison to children who use SNEA in a population of MNE patients with no underlying Attention deficit hyperactivity disorder (ADHD) in a 3 month period.

Secondary Objectives

To ascertain if familial incidence of nocturnal enuresis has an effect on outcomes

5.1 General Design Description The investigators propose the following study in patients who have been evaluated for primary nocturnal enuresis in our Yale New Haven Clinics.

  • All patients to be evaluated for nocturnal enuresis will undergo standard evaluation and initial treatment for nocturnal enuresis which includes:
  • Assessment Of Bowel Habits,
  • Fill Out A Questionnaire To Evaluate For Voiding Dysfunction
  • Treatment with routine bedwetting protocol of:
  1. Stopping drinks 1 HR before bedtime, meals at least 3 hrs before bedtime, eliminating milk and ice cream from dinner and on, making sure that bowel movements are occurring 4 times per week and treating appropriately if necessary.
  2. On return visit bedwetters and parents will be given the option of using medication , no further treatment, or alarm therapy.
  3. If patients choose alarm therapy, they will be asked if they wish to participate in the Randomized study comparing GoGoband® vs SNEA.
  4. Alarms will be provided to the patients free of cost to participants
  5. Patients in the alarm group will be treated for 3 months continuously.
  6. Patients in the SNEA group will record nightly if they wet their clothes and the report will be recorded and reviewed weekly
  7. GoGoband® patients' data will be automatically saved on the HIPPA Compliant servers and subsequently reviewed at the end of the week.
Being tested
gogoband, SNEA group
Keywords
bedwetting, biometric, artificial intelligence, machine learning, heart rate variability, nocturnal enuresis, enuresis, urinary incontinence
Medical subject headings
Nocturnal Enuresis, Urinary Incontinence, Enuresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gogobandDevice

    use of biometric alarm to wake patient prior to wetting

  • SNEA groupDevice

    Also called standard bedwetting alarm

    standard bedwetting alarm is used to treat patients, alarm sounds after wetting accident has occurred

Study groups in NCT05214131
Study groupRoleWhat they receive
gogoband alarmExperimentalpatients will be assigned to the novel bedwetting alarm
Receives: Device: gogoband
standard nocturnal enuresis alarm (SNEA) groupActive comparatorthis is the standard bedwetting alarm that is presently available through out the world
Receives: Device: SNEA group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Wet Nights

    Comparison of alarms are to determine whether the GoGoband®] is as effective or more effective in comparison to children who use SNEA in a population of MNE patients with no underlying ADHD. The number of wet nights in each group will be compared to each other providing a comparison of the data.

    The data will be compared using either a T test or Kruskal Wallis or anova depending on the number of comparisons performed and the data distribution is normal or not. If patient numbers are less than 10 per group no statistical analysis will be performed.

    Measured: 3 month period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2022
  2. Study start29 Apr 2022
  3. Primary completion13 Jun 2025
  4. Study completion13 Jun 2025

Why it stopped: low enrollment, patients did not want to be randomized into the regular alarm group, poor compliance with standard alarm

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05214131
Sponsor's protocol ID
2000031281
Status last verified
Feb 2026
First submitted
25 Jan 2022
Last updated
9 Mar 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in